177 related articles for article (PubMed ID: 24331455)
1. Interaction of the neuropeptide S receptor gene Asn¹⁰⁷Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour.
Laas K; Reif A; Akkermann K; Kiive E; Domschke K; Lesch KP; Veidebaum T; Harro J
Int J Neuropsychopharmacol; 2014 Apr; 17(4):541-52. PubMed ID: 24331455
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption.
Laas K; Reif A; Akkermann K; Kiive E; Domschke K; Lesch KP; Veidebaum T; Harro J
Addict Biol; 2015 May; 20(3):605-16. PubMed ID: 24754478
[TBL] [Abstract][Full Text] [Related]
3. A functional NPSR1 gene variant and environment shape personality and impulsive action: a longitudinal study.
Laas K; Reif A; Kiive E; Domschke K; Lesch KP; Veidebaum T; Harro J
J Psychopharmacol; 2014 Mar; 28(3):227-36. PubMed ID: 23325374
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for the association of the NPSR1 gene A/T polymorphism (Asn107Ile) with impulsivity and hyperactivity.
Laas K; Eensoo D; Paaver M; Lesch KP; Reif A; Harro J
J Psychopharmacol; 2015 Aug; 29(8):878-83. PubMed ID: 25744621
[TBL] [Abstract][Full Text] [Related]
5. A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.
Vaht M; Kiive E; Veidebaum T; Harro J
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26861143
[TBL] [Abstract][Full Text] [Related]
6. Extending the vulnerability-stress model of mental disorders: three-dimensional
Schiele MA; Herzog K; Kollert L; Schartner C; Leehr EJ; Böhnlein J; Repple J; Rosenkranz K; Lonsdorf TB; Dannlowski U; Zwanzger P; Reif A; Pauli P; Deckert J; Domschke K
Br J Psychiatry; 2020 Nov; 217(5):645-650. PubMed ID: 32321595
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide S receptor (NPSR1) gene variation modulates response inhibition and error monitoring.
Beste C; Konrad C; Uhlmann C; Arolt V; Zwanzger P; Domschke K
Neuroimage; 2013 May; 71():1-9. PubMed ID: 23319044
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.
Alshogran OY; Al-Eitan LN; Altawalbeh SM; Khalil AA; Alqudah MAY; Oweis AO; Aman HA; Alhawari HH
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109657. PubMed ID: 31132388
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide S receptor gene Asn107 polymorphism in obese male individuals in Pakistan.
Ahmad A; Almsned F; Ghazal P; Ahmed MW; Jafri MS; Bokhari H
PLoS One; 2020; 15(12):e0243205. PubMed ID: 33332443
[TBL] [Abstract][Full Text] [Related]
10. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample.
Mather AA; Cox BJ; Enns MW; Sareen J
J Psychosom Res; 2009 Apr; 66(4):277-85. PubMed ID: 19302884
[TBL] [Abstract][Full Text] [Related]
11. Association of NPSR1 rs324981 polymorphism and treatment response to antidepressants in Chinese Han population with generalized anxiety disorder.
He Q; Shen Z; Ren L; Wang X; Qian M; Zhu J; Shen X
Biochem Biophys Res Commun; 2018 Sep; 504(1):137-142. PubMed ID: 30190127
[TBL] [Abstract][Full Text] [Related]
12. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.
Lennertz L; Franke PE; Grabe HJ; Rampacher F; Schulze-Rauschenbach S; Guttenthaler V; Ruhrmann S; Pukrop R; Klosterkötter J; Falkai P; Maier W; Wagner M; Mössner R
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1951-8. PubMed ID: 23680103
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of suicidal behaviour in general practice].
Vörös V; Osváth P; Ruzsics I; Nagy T; Kovács L; Varga J; Fekete S; Kovács A
Orv Hetil; 2006 Feb; 147(6):263-8. PubMed ID: 16610617
[TBL] [Abstract][Full Text] [Related]
14. Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders.
Pawlak J; Dmitrzak-Węglarz M; Skibińska M; Szczepankiewicz A; Leszczyńska-Rodziewicz A; Rajewska-Rager A; Zaremba D; Czerski P; Hauser J
Gen Hosp Psychiatry; 2013; 35(4):427-32. PubMed ID: 23643033
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide S receptor gene: fear-specific modulations of prefrontal activation.
Tupak SV; Reif A; Pauli P; Dresler T; Herrmann MJ; Domschke K; Jochum C; Haas E; Baumann C; Weber H; Fallgatter AJ; Deckert J; Ehlis AC
Neuroimage; 2013 Feb; 66():353-60. PubMed ID: 23103692
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide S receptor gene (NPSR) and life events: G × E effects on anxiety sensitivity and its subdimensions.
Klauke B; Deckert J; Zwanzger P; Baumann C; Arolt V; Pauli P; Reif A; Domschke K
World J Biol Psychiatry; 2014 Jan; 15(1):17-25. PubMed ID: 22404660
[TBL] [Abstract][Full Text] [Related]
17. Nice guys: Homozygocity for the TPH2 -703G/T (rs4570625) minor allele promotes low aggressiveness and low anxiety.
Laas K; Kiive E; Mäestu J; Vaht M; Veidebaum T; Harro J
J Affect Disord; 2017 Jun; 215():230-236. PubMed ID: 28342337
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide S receptor gene -- converging evidence for a role in panic disorder.
Domschke K; Reif A; Weber H; Richter J; Hohoff C; Ohrmann P; Pedersen A; Bauer J; Suslow T; Kugel H; Heindel W; Baumann C; Klauke B; Jacob C; Maier W; Fritze J; Bandelow B; Krakowitzky P; Rothermundt M; Erhardt A; Binder EB; Holsboer F; Gerlach AL; Kircher T; Lang T; Alpers GW; Ströhle A; Fehm L; Gloster AT; Wittchen HU; Arolt V; Pauli P; Hamm A; Deckert J
Mol Psychiatry; 2011 Sep; 16(9):938-48. PubMed ID: 20603625
[TBL] [Abstract][Full Text] [Related]
19. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.
Lennertz L; Quednow BB; Schuhmacher A; Petrovsky N; Frommann I; Schulze-Rauschenbach S; Landsberg MW; Steinbrecher A; Höfels S; Pukrop R; Klosterkötter J; Franke PE; Wölwer W; Gaebel W; Häfner H; Maier W; Wagner M; Mössner R
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1205-15. PubMed ID: 22078257
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
